Saffron extract and mood: what the study found
This study, published in Nutrients, investigated the effects of a safranal-standardized saffron extract on behavioral, neuroendocrine, and metabolic parameters in aged mice, focusing on age-related changes in mood, memory, and metabolic balance.
Using a rigorously characterized extract standardized for safranal (2%) and crocins (3%), the research reported that oral administration led to measurable systemic bioavailability of safranal and showed dose-dependent effects. A higher dose was associated with effects on behaviors related to stress and emotional balance and on recognition memory, while a lower dose supported maintenance of body weight during aging and modulated hepatic lipid metabolism.
At the mechanistic level, Safforce+® modulated key neuropeptides involved in the body’s normal stress response, including increased hypothalamic neuropeptide Y (NPY) and reduced corticotropin-releasing hormone (CRH) and hypocretin (HCRT) signaling. These observations were accompanied by lower inflammation-related signaling in the prefrontal cortex and by activation of endocannabinoid and paracannabinoid pathways in the hippocampus — mechanisms associated with emotional balance, sleep regulation, and memory consolidation.
Together, these findings position content-standardized saffron extracts such as Safforce+® as multi-target ingredients with potential relevance for emotional well-being, cognitive performance, and metabolic balance during aging, while also addressing the reproducibility and authenticity challenges common in the saffron market.
The research described above was conducted in a preclinical (animal) model and is intended for scientific and product-development audiences. These statements have not been evaluated by the Food and Drug Administration. Safforce+® is an ingredient and is not intended to diagnose, treat, cure, or prevent any disease.